New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent
The vaccine is personalized to a patientβs tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
The vaccine is personalized to a patientβs tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
Space is becoming a bigger part of everyday business, from communications and Earth observation to defense and predictive analytics. Voyager Technologies CEO Dylan Taylor and Muon Space President Gregory Smirin explain how cheaper launches, more satellite constellations and advances in AI are pushing the space economy into a new phase. Watch more from the CNBC CONVERGE LIVE conversation in Singapore to hear how the business of orbit is moving from exploration to infrastructure.
TFG London has apologised to customers for disruption after it identified a "cybersecurity incident" on Sunday.